Medical grade wearables provider Mawi is integrating proprietary ECG analytics from New York software company AccurKardia into a cardiac monitoring watch.

AccurKardia provides clinical-grade, device-agnostic, automated electrocardiogram (ECG) analytics. It is collaborating with Mawi to help enable cardiac-care through remote patient monitoring.

As part of the collaboration, AccurKardia’s device-agnostic automated ECG analytics will complement Mawi’s expertise in designing, developing and deploying cardiac monitoring devices and wearables. This joint offering will enable the early detection of potentially life-threatening cardiovascular conditions that may be otherwise missed or diagnosed at a late stage.

“Joining forces will provide our new Mawi Watch with next level ECG analytics as we create a full integration for chronic patients’ cardiac remote monitoring,” said Ron Fridman, CEO of Mawi. “We’re on a mission to beat the heart’s silent killers and our new cardiac monitoring will empower clinicians at all stages of patient management, identifying cardiovascular issues earlier and more effectively.”

Juan Jiménez, CEO of AccurKardia, added: “We are excited to work with Mawi, an innovative medtech player developing a new generation of cardiac monitoring devices and wearables. Both AccurKardia and Mawi have a shared goal of improving patient outcomes through superior remote patient monitoring. By equipping the next generation of wearables with automated ECG analysis capabilities, together we are raising the bar in cardiovascular health monitoring, improving access to quality care and ultimately saving lives.”

AccurKardia is a digital-first and software-only healthcare company focused on combining smart devices, actionable data and efficient clinical intervention to improve medical outcomes and save lives. It provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies.

Founded in 2017 by four Ukrainians, Mawi operates in Europe, the USA and the Middle East and works with more than 60 hospitals worldwide. It brings together FDA and CE-cleared wearables and smart analytics software, providing healthcare professionals with a suite of cardiac monitoring tools to cover the full risk spectrum of patients from short-term ambulatory Holter monitoring to long-term remote patient monitoring.

The Mawi Watch is a medical-grade, easy-to-use wearable for continuous cardiac health monitoring. The device is elder-friendly, being smartphone-free, working right out of the box and pre-set up at the clinic. Waterproof and comfortable for day and night use, it provides access to round-the-clock patient health data gathering with up to two weeks’ battery life. With its pulse wave analysis approach, the watch tracks blood pressure continuously, passively and with no cuffs needed. It tracks silent AFibs, combining photoplethysmography (PPG) and ECG technologies. The device also tracks core cardiac health vitals, including heart rate, blood oxygen, respiratory rate and heart rate variability. The watch comes with remote patient monitoring software, which provides healthcare practitioners with real-time health data and high-risk alerts.